XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Shares
ATM offerings
Common Shares
Registered direct offering
Common Shares
Public offering
Common Shares
Additional Paid in Capital
ATM offerings
Additional Paid in Capital
Registered direct offering
Additional Paid in Capital
Public offering
Additional Paid in Capital
Accumulated Deficit
Noncontrolling Interest
ATM offerings
Registered direct offering
Public offering
Total
Beginning Balance at Sep. 30, 2023       $ 1       $ 307,398,305 $ (302,447,147) $ (78,747)       $ 4,872,412
Beginning Balance (in shares) at Sep. 30, 2023       911                    
Increase (Decrease) in Stockholders' Equity                            
Stock based compensation expense               340,705           340,705
Common stock issued in ATM, net of offering costs         $ 45,566           $ 45,566      
Common stock issued in ATM, net of offering costs (In shares) 6                          
Deemed dividend - warrant repricing               77,757 (77,757)          
Net loss                 (1,105,100) (25,181)       (1,130,281)
Ending Balance at Dec. 31, 2023       $ 1       307,862,333 (303,630,004) (103,928)       4,128,402
Ending Balance (in shares) at Dec. 31, 2023       917                    
Beginning Balance at Sep. 30, 2023       $ 1       307,398,305 (302,447,147) (78,747)       4,872,412
Beginning Balance (in shares) at Sep. 30, 2023       911                    
Increase (Decrease) in Stockholders' Equity                            
Net loss                           (3,774,563)
Ending Balance at Jun. 30, 2024       $ 14       318,767,985 (306,376,012) (157,532)       12,234,455
Ending Balance (in shares) at Jun. 30, 2024       13,738                    
Beginning Balance at Dec. 31, 2023       $ 1       307,862,333 (303,630,004) (103,928)       4,128,402
Beginning Balance (in shares) at Dec. 31, 2023       917                    
Increase (Decrease) in Stockholders' Equity                            
Stock based compensation expense               171,004           171,004
Common stock issued in ATM, net of offering costs         $ 18,831 $ 161         $ 18,831 $ 161    
Common stock issued in ATM, net of offering costs (In shares) 6 215                        
Deemed dividend - warrant repricing               155,330 (155,330)          
Share issued upon restricted stock vesting (in shares)       19                    
Net loss                 (4,470,474) (23,309)       (4,493,783)
Ending Balance at Mar. 31, 2024       $ 1       308,207,659 (308,255,808) (127,237)       (175,385)
Ending Balance (in shares) at Mar. 31, 2024       1,157                    
Increase (Decrease) in Stockholders' Equity                            
Exercise of warrants       $ 12       4,928           4,940
Exercise of warrants (in shares)       11,501                    
Common stock and pre-funded warrants issued in public offering, net of offering costs     $ 1       $ 10,525,062           $ 10,525,063  
Common stock and pre-funded warrants issued in public offering, net of offering costs (in shares)     967                      
Stock based compensation expense               30,336           30,336
Adjustment for reverse split (in Shares)       113                    
Net loss                 1,879,796 (30,295)       1,849,501
Ending Balance at Jun. 30, 2024       $ 14       318,767,985 (306,376,012) (157,532)       12,234,455
Ending Balance (in shares) at Jun. 30, 2024       13,738                    
Beginning Balance at Sep. 30, 2024       $ 14       318,815,358 (309,672,755) (174,532)       $ 8,968,085
Beginning Balance (in shares) at Sep. 30, 2024       13,755                   13,755
Increase (Decrease) in Stockholders' Equity                            
Exercise of warrants       $ 3       508,597           $ 508,600
Exercise of warrants (in shares)       3,422                    
Exercise of warrants, cashlessly       $ 28       (28)            
Exercise of warrants, cashlessly (in shares)       27,895                    
Stock based compensation expense               28,973           28,973
Common stock and pre-funded warrants issued in registered direct offering, net of offering costs       $ 27       5,712,673           5,712,700
Common stock and pre-funded warrants issued in registered direct offering, net of offering costs (in shares)       27,083                    
Deemed dividend - warrant repricing               14,907,223 (14,907,223)          
Net loss                 (2,639,412) (29,301)       (2,668,713)
Ending Balance at Dec. 31, 2024       $ 72       339,972,796 (327,219,390) (203,833)       12,549,645
Ending Balance (in shares) at Dec. 31, 2024       72,155                    
Beginning Balance at Sep. 30, 2024       $ 14       318,815,358 (309,672,755) (174,532)       $ 8,968,085
Beginning Balance (in shares) at Sep. 30, 2024       13,755                   13,755
Increase (Decrease) in Stockholders' Equity                            
Net loss                           $ (9,988,942)
Ending Balance at Jun. 30, 2025       $ 902       381,150,267 (373,888,601) (274,524)       $ 6,988,044
Ending Balance (in shares) at Jun. 30, 2025       901,500                   901,500
Beginning Balance at Dec. 31, 2024       $ 72       339,972,796 (327,219,390) (203,833)       $ 12,549,645
Beginning Balance (in shares) at Dec. 31, 2024       72,155                    
Increase (Decrease) in Stockholders' Equity                            
Exercise of warrants       $ 30       984,142           984,172
Exercise of warrants (in shares)       30,003                    
Exercise of warrants, cashlessly       $ 315       (315)            
Exercise of warrants, cashlessly (in shares)       314,845                    
Stock based compensation expense               26,511           26,511
Deemed dividend - warrant repricing               23,919,429 (23,919,429)          
Adjustment for reverse split       $ 5       (5)            
Adjustment for reverse split (in Shares)       5,092                    
Net loss                 (3,304,175) (31,945)       (3,336,120)
Ending Balance at Mar. 31, 2025       $ 422       364,902,558 (354,442,994) (235,778)       10,224,208
Ending Balance (in shares) at Mar. 31, 2025       422,095                    
Increase (Decrease) in Stockholders' Equity                            
Exercise of warrants       $ 139       722,917           723,056
Exercise of warrants (in shares)       138,557                    
Exercise of warrants, cashlessly       $ 267       (267)            
Exercise of warrants, cashlessly (in shares)       267,236                    
Stock based compensation expense               24,889           24,889
Deemed dividend - warrant repricing               15,500,244 (15,500,244)          
Adjustment for reverse split       $ 74       (74)            
Adjustment for reverse split (in Shares)       73,612                    
Net loss                 (3,945,363) (38,746)       (3,984,109)
Ending Balance at Jun. 30, 2025       $ 902       $ 381,150,267 $ (373,888,601) $ (274,524)       $ 6,988,044
Ending Balance (in shares) at Jun. 30, 2025       901,500                   901,500